Chenyang Liu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Left Ventricular

Acute Myocardial Infarction

Top Venues

Nature communications

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Qin-Fen Chen, Jiahao Zou, Christos S Katsouras, Shenban You, Jian Zhou, Hang-Bin Ge, Chenyang Liu, Xi Zhou, Chao Ni, Yangdi Peng, Chenlv Hong, Wei-Hong Lin, Xiao-Dong Zhou
Clinical Characteristics and Outcomes in Patients With Apical and Nonapical Hypertrophic Cardiomyopathy. Journal of the American Heart Association (2024)
Qin-Fen Chen, Liangguo Wang, Christos S Katsouras, Mengge Gong, Chenyang Liu, Liyou Lian, Xiaoyan Chen, Xuemeng Zhu, Chen Chen, Xiaofang Feng, Wei-Hong Lin, Xiao-Dong Zhou
Clinical characteristics and prognostic importance of anticoagulant use in ischemic left ventricular aneurysm: a retrospective cohort study. Nature communications 15 (1) (2024)
Qin-Fen Chen, Liangguo Wang, Christos S Katsouras, Mengge Gong, Chenyang Liu, Liyou Lian, Xiaoyan Chen, Xuemeng Zhu, Chen Chen, Xiaofang Feng, Wei-Hong Lin, Xiao-Dong Zhou
Clinical characteristics and prognostic importance of anticoagulant use in ischemic left ventricular aneurysm: a retrospective cohort study. Nature communications 15 (1) (2024)
Qin-Fen Chen, Liangguo Wang, Christos S Katsouras, Mengge Gong, Chenyang Liu, Liyou Lian, Xiaoyan Chen, Xuemeng Zhu, Chen Chen, Xiaofang Feng, Wei-Hong Lin, Xiao-Dong Zhou
Clinical characteristics and prognostic importance of anticoagulant use in ischemic left ventricular aneurysm: a retrospective cohort study. Nature communications 15 (1) (2024)
Qin-Fen Chen, Liangguo Wang, Christos S Katsouras, Mengge Gong, Chenyang Liu, Liyou Lian, Xiaoyan Chen, Xuemeng Zhu, Chen Chen, Xiaofang Feng, Wei-Hong Lin, Xiao-Dong Zhou
Clinical characteristics and prognostic importance of anticoagulant use in ischemic left ventricular aneurysm: a retrospective cohort study. Nature communications 15 (1) (2024)